54 results
Page 2 of 3
6-K
EX-99.2
5g4m8mnk7
4 May 23
Index to Condensed Consolidated Financial Statements
4:04pm
6-K
EX-99.3
9qgbid
3 Nov 22
Index to Condensed Consolidated Financial Statements
10:31am
6-K
EX-99.2
v9y hosy8
4 Aug 22
Index to Condensed Consolidated Financial Statements
4:06pm
6-K
EX-99.3
7un0g vve
4 Aug 22
Index to Condensed Consolidated Financial Statements
4:06pm
6-K
EX-99.2
wsqy3cx6
5 May 22
Index to Condensed Consolidated Financial Statements
12:00am
6-K
EX-1
05g5 w0zc1s400
30 Jun 21
Annual Report and Accounts
6:05am
424B5
pok4 nw5c
11 Feb 21
Prospectus supplement for primary offering
5:16pm
424B5
ydn l6hfdh6z1
8 Feb 21
Prospectus supplement for primary offering
5:27pm
6-K
EX-99.3
9c4u2y
7 Dec 20
Updated data from the ALLCAR study suggests AUTO1’s potential for transformational activity in adult patients with r/r ALL
4:00pm
6-K
EX-99.1
0g9qb
7 Dec 20
Updated data from the ALLCAR study suggests AUTO1’s potential for transformational activity in adult patients with r/r ALL
4:00pm
6-K
EX-99.2
dkh9wk6 za2rww9ey7
7 Dec 20
Updated data from the ALLCAR study suggests AUTO1’s potential for transformational activity in adult patients with r/r ALL
4:00pm
6-K
qy0cu6d
7 Dec 20
Updated data from the ALLCAR study suggests AUTO1’s potential for transformational activity in adult patients with r/r ALL
4:00pm
6-K
EX-99.1
zhtwg1xg7v
18 Sep 20
Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ESMO
7:12am
6-K
EX-1
pgmhdysnlpdpg
26 May 20
Current report (foreign)
4:31pm
424B4
ssrt5h9uqj00m roy
11 Apr 19
Prospectus supplement with pricing info
4:10pm
6-K
hd9wmz
8 Apr 19
Autolus Announces Proposed Public Offering in the United States
5:30pm